Agustin Vega-Crespo - Concepedia

Author

Agustin Vega-Crespo

University of California, Los Angeles ORCID

Also Known As

Agustin Vega-Crespo, Vega-Crespo, Agustin

120

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Parker Institute for Cancer Immunotherapy UCLA Medical Center University of Lausanne UCLA Health

About

Agustin Vega-Crespo is an author at University of California, Los Angeles specializing in immunotherapy, immunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	750
2	Immunology	4	4	750
3	Cell Biology	2	2	412
4	Pharmacology	1	1	150
5	Cancer Therapeutics	1	1	150

Agustin Vega-Crespo

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma Catherine S. Grasso, Jennifer Tsoi, Mykola Onyshchenko, Cancer Cell Tumor ImmunologyCancer ImmunosurveillanceMelanomaImmunologyTumor Immunity	2020	361
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy Cristina Puig-Saus, Barbara Sennino, Songming Peng, Nature Pd-1 Blockade TherapyCancer ImmunosurveillanceImmunologyImmune Checkpoint InhibitorCd4 T Cell Responses	2023	188
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial Ari M. Vanderwalde, Shay Bellasea, Kari Kendra, Nature Medicine MedicineMelanomaPharmacologyImmunologyImmune Checkpoint Inhibitor	2023	150
Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade Davis Y. Torrejon, Gabriel Abril-Rodríguez, Ameya S. Champhekar, Cancer Discovery	2020	137
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma Anusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi, Science Translational Medicine	2020	123
Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma Prashanthi Dharanipragada, Xiao Zhang, Sixue Liu, Cancer Discovery	2023	79
Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity Aayoung Hong, Marco Piva, Sixue Liu, Cancer Discovery	2020	61
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma Catherine S. Grasso, Jennifer Tsoi, Mykola Onyshchenko, Cancer Cell Tumor ImmunologyCancer ImmunosurveillanceMelanomaImmunologyTumor Immunity	2020	51
Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status Jason P. Awe, Patrick Lee, Cyril Y. Ramathal, Stem Cell Research & Therapy	2013	48
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes Sameeha Jilani, Justin D. Saco, Edurne Mugarza, Nature Communications	2024	43

Page 1